What is the COVID-19 Vaccine Disability Dashboard?
The COVID-19 Vaccine disability dashboard is a resource that contains the amalgamated information for COVID-19 Vaccine eligibility across Canada. The dashboard highlights the current phase and eligibility statuses for the COVID-19 vaccine specifically discussing the Current Vaccine Rollout Phase, Current general age-related eligibility, Long term care phase, other congregate care settings phase, chronic conditions, other disability-related groups phase, and caregivers for people with disabilities. The dashboard also includes the local definitions for the disability related groups.
What is the purpose of the COVID-19 Vaccine Disability Dashboard?
The purpose of the COVID-19 Vaccine disability dashboard is to provide a clear presentation of the current eligibility requirements for the COVID-19 vaccine. Specifically, the dashboard was created to highlight how people with disabilities are being considered as part of the vaccine rollout. Through the included tables, the dashboard provides information on Current eligibility for the COVID-19 vaccine, who qualifies for each of the vaccines in the given province/territory, the local definition of chronic conditions, who falls under the other disability-related groups, and caregivers for people with disabilities. Through this dashboard, we aim to provide a clear and concise indication of eligibility requirements and the considerations being made for individuals with disabilities during the COVID-19 vaccine rollout.
How long will the dashboard run?
The dashboard is designed to present this information and keep it updated on a weekly basis. We are committed to doing so as it is relevant.
What do we hope to achieve by having the COVID-19 Vaccine Disability Dashboard?
Our goals for this project is to provide accessible, clear, concise, and thorough understanding of COVID-19 vaccine eligibility for individuals with disabilities. We aim to help provide an understanding of how people with disabilities are being considered and prioritized during the COVID-19 vaccine rollout.